Vigmed AB signs Distribution Agreement for Scandinavia with CODAN companies.

Report this content

The first Distribution Agreement signed for Vigmed AB, turned out to be for their home markets in Scandinavia and is a good match. CODAN, being an established company within Vigmed’s main business segments of infusion and injection, and Vigmed adding the safety products that will complete the CODAN product portfolio.

The agreement with CODAN can be seen as Vigmed’s next partnership phase. The first was to establish a contract manufacturing platform, and now the second phase of establishing a strong European distribution network has begun. The products will be sold under the brand names of Vigmed, and can be seen as the beginning of a close sales, marketing and product development cooperation.

Finn Ketler, CEO Vigmed AB  & Thomas Hornstrup, Country Manager CODAN DEHA ApS shake hands on the new distribution contract.

“As it is very important to have established contacts to customers and key decision makers, when wanting to penetrate a market fast, we are very pleased in having CODAN as our partner” says Finn Ketler, CEO of Vigmed.

Steen Kruse, Sales Manager CODAN, explains “The Vigmed products match our existing product lines very well. They are a valuable addition to the strategic line of Infusion products with which we are already active in the market. With the "safety" aspect becoming an increasingly important parameter in the Medical Device area we consider the Vigmed products to be an important new development for CODAN which will support our continued effort to provide quality products to our customers.”

The joint product launch in the Scandinavian countries of the CLiP® Ven line is expected to take place in Q2 of this year, with deliveries taking place from March onwards.

For further information contact:

Vigmed:
Chairman of the board, Lennart Holm, +46 70-630 8562 or
CEO, Finn Ketler, +46 42 600 5311

CODAN:
Sales Manager, Steen Kruse, +45 29 264419

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has approximately 15 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor.

Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s website: www.vigmed.com


CODAN is a privately owned company with approximately 1.500 employees and factories and sales organizations located in Europe and USA. CODAN has been active in the Medical Device market for over 50 years. CODAN offers a complete range of high quality Infusion Devices, Infusion- and Syringe Pumps, Blood Pressure Monitoring products, Syringes and accessories manufactured in our own production facilities. The products are marketed and sold world wide and are produced in accordance with all relevant national and international standards for our type of products. Further information can be found at: www.codan.de.

Tags:

Media

Media

Documents & Links

Quotes

As it is very important to have established contacts to customers and key decision makers, when wanting to penetrate a market fast, we are very pleased in having CODAN as our partner
Finn Ketler, CEO of Vigmed
The Vigmed products match our existing product lines very well. They are a valuable addition to the strategic line of Infusion products with which we are already active in the market. With the
Steen Kruse, Sales Manager CODAN